Inspire Medical Systems, Inc. (INSP)
NYSE · Healthcare · Medical Devices
$70.75+1.11%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $2.0B
- P/E (trailing)
- 15.4
- Forward P/E
- 45.7
- 52-week range
- $38.91 – $147.03
- 52-week change
- −8.38%
- EPS (trailing)
- $4.59
- Analyst rating
- 2.7 Hold
- Next earnings
- Nov 2, 2026
Fiscal year to Dec 2025
- Revenue
- $912M (+13.60%)
- Net income
- $145M
- Operating margin
- 5.6%
- Diluted EPS
- $4.89
- Free cash flow
- $78.5M
From the company’s annual report on SEC EDGAR.
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Headquarters: Golden Valley, United States · 1,333 employees · inspiresleep.com